.Passion for Innovation. Compassion for Patients. With over 120 years of experience and more than 17,000 employees in over 20 countries, Daiichi Sankyo is dedicated to discovering, developing, and delivering new standards of care that enrich the quality of life around the world. In Europe, we focus on two areas: The goal of our Specialty Business is to protect people from cardiovascular disease, the leading cause of death in Europe, and help patients who suffer from it to enjoy every precious moment of life. In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel therapies for people with cancer. Our European headquarters are in Munich, Germany, and we have affiliates in 13 European countries and Canada. Medical Expert Hematology (m/f/x) The Position In your function you will act as the primary point of contact and the local key scientific expert for Quizartinib and AML disease with internal and external stakeholders in "Country XYZ", in the Daiichi-Sankyo European Medical Affairs team and report directly to the Director European Medical Affairs Hematology (dotted line with the country relevant member). This is a mixed position mainly based on MSL activities (70-80% on the field) and with national office-based activities (for example: national advisory board, a symposia, compliance for material approvals, HCP contracts, etc). Key Responsibilities: Communicate the Scientific value of hematological products (focus on Quizartinib), to internal and external stakeholders and have a customer centricity approach involving KEEs, nurses, scientific country AML collaborative groups. Mapping the Key External Experts (KEE) tier 1 and 2 as well as to establish and maintain professional relationships with medical and scientific opinion leaders and relevant medical societies. Support medical affairs activities and generation and dissemination of data to the main/key stakeholders. Discuss ISS with KEEs if there is a need aligned with the regional medical director. Ability to manage a country budget aligned with the regional medical director in line with company policies. Be the first point of contact in the country with hematologists. Be the expert regarding AML disease, treatments landscape and Quizartinib medical value. Through scientific interactions, champion the medical value of hematology compounds (focus in Quizartinib) in the pipeline and contribute to the fostering of innovative approaches. Develop and execute an external stakeholder engagement plan aligned with the regional medical director in charge of Quizartinib. Coordinate and align successfully the cross functional prelaunch and launch activities for Hematology compounds (focus in Quizartinib), including Market Access activities, such as support on value dossier, access at regional level and regulatory support. Set up local advisory boards and symposia around local key congresses aligned with the European strategy
